Fritextsökning
Innehållstyper
-
Abbott expands by acquisition
An acquisition gives Abbott a leadership position in another large and growing medical device segment.
-
Swiss allergy therapy convinces
Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.
-
Det kemiska julbordet
Redan när vi stiger innanför dörren i juletid signalerar vår näsa att julen är en högtid där kemin spelar stor roll.
-
Robotarm till kliniska studier
Forskaren Max Ortiz Catalan, som varit med och tagit fram den första tankestyrda armprotesen med inopererade elektroder, berättar om nästa steg för projektet.
-
Läkemedelsrening behöver inte vara dyr
Tekniken för avancerad rening av läkemedelsrester på svenska avloppsreningsverk finns, till en kostnad av cirka en krona per kubikmeter vatten.
-
KI i open innovation-samarbete
Genom projektet Ultra-DD ska tidig läkemedelsutveckling bli mer effektiv.
-
Vitrolife wants to acquire Medicult
The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.
-
Virusforskare får Scilifelabpris
Forskningsinstitutet delar i samarbete med tidskriften Science ut pris till unga forskare.
-
Danisco first with green emulsifier
A new sustainable emulsifier from Danisco meets the increasing consumer demand for ethically correct consumer goods.
-
Medicult disclaims Swedish offer
The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.
-
De ska basa över Scilifelab
I dag tog regeringen beslut om hur forskningscentrumet Scilifelab ska styras.
-
International models among science parks
Science parks have become a part of modern communities. With science parks in Oxford, Cambridge and Nice setting good examples, a special potential emerged. Cou...
-
New influenza vaccine to EU
The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.
-
Elekta gets ok from China
The Swedish medtech comapny Elekta has received approval from the Chinese authority State Food and Drug Administration, SFDA, to sell its linear accelerator in China.
-
Meda gets access to Asia
The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.
-
Medtech giant separates
Due to the global economic situation, the medtech companies Q-Med and the Palomar Medical Technologies has terminated its international agreement.
-
Martin Bergö: "The Idea is the Thing"
Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recogniz...
-
Europas enda bantningsmedel får grönt ljus efter granskning
EMA anser att nyttan överväger risken vad gäller läkemedel som baseras på orlistat.
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
Bringwell byter chef
Tillförordnade finanschefen Jonny Hoffman tar över tyglarna på bolaget tills en fast vd har utsetts.
-
Positive combined cancer therapy
Topotarget announces positive data with new treatment against colorectal cancer.
-
Orion cuts 205 jobs
The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.
-
”Antibiotikaresistens kan bli nästa stora kris”
Sarah Aiosa började som vd på MSD Sverige mitt under coronapandemin. Hennes ledarstyrka sattes genast på prov då hon fick börja med att krishantera på distans f...
-
Finnish Innovation Fund gets new leader
The Supervisory Board of the Finnish Innovation Fund Sitra has appointed members of the Board, including a new president.